335 related articles for article (PubMed ID: 8577041)
1. [Krabbe disease (globoid cell leukodystrophy)].
Sakai N; Inui K; Okada S
Nihon Rinsho; 1995 Dec; 53(12):2947-51. PubMed ID: 8577041
[TBL] [Abstract][Full Text] [Related]
2. Somatic cell genetic analysis of the galactocerebrosidase gene: lack of complementation in human Krabbe disease/twitcher mouse cell hybrids.
Skiba MC; Lyerla TA; Konola JT; Raghavan S
J Neurosci Res; 1990 Dec; 27(4):472-8. PubMed ID: 2079710
[TBL] [Abstract][Full Text] [Related]
3. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers.
Victoria T; Rafi MA; Wenger DA
Genomics; 1996 May; 33(3):457-62. PubMed ID: 8661004
[TBL] [Abstract][Full Text] [Related]
4. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements.
Shen JS; Watabe K; Ohashi T; Eto Y
Gene Ther; 2001 Jul; 8(14):1081-7. PubMed ID: 11526455
[TBL] [Abstract][Full Text] [Related]
5. Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta).
Baskin GB; Ratterree M; Davison BB; Falkenstein KP; Clarke MR; England JD; Vanier MT; Luzi P; Rafi MA; Wenger DA
Lab Anim Sci; 1998 Oct; 48(5):476-82. PubMed ID: 10090061
[TBL] [Abstract][Full Text] [Related]
6. Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Graziano AC; Parenti R; Avola R; Cardile V
Apoptosis; 2016 Jan; 21(1):25-35. PubMed ID: 26459425
[TBL] [Abstract][Full Text] [Related]
7. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate.
Luzi P; Rafi MA; Victoria T; Baskin GB; Wenger DA
Genomics; 1997 Jun; 42(2):319-24. PubMed ID: 9192853
[TBL] [Abstract][Full Text] [Related]
9. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher).
Shen JS; Watabe K; Meng XL; Ida H; Ohashi T; Eto Y
J Neurosci Res; 2002 Jun; 68(5):588-94. PubMed ID: 12111848
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment.
Sakai N
Brain Dev; 2009 Aug; 31(7):485-7. PubMed ID: 19332366
[TBL] [Abstract][Full Text] [Related]
13. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
14. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.
Lin D; Fantz CR; Levy B; Rafi MA; Vogler C; Wenger DA; Sands MS
Mol Ther; 2005 Sep; 12(3):422-30. PubMed ID: 15996520
[TBL] [Abstract][Full Text] [Related]
15. Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy.
Lee WC; Tsoi YK; Troendle FJ; DeLucia MW; Ahmed Z; Dicky CA; Dickson DW; Eckman CB
FASEB J; 2007 Aug; 21(10):2520-7. PubMed ID: 17403939
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
Wenger DA; Rafi MA; Luzi P
Hum Mutat; 1997; 10(4):268-79. PubMed ID: 9338580
[TBL] [Abstract][Full Text] [Related]
17. [Krabbe disease (globoid cell leukodystrophy)].
Inui K
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):375-8. PubMed ID: 9645086
[No Abstract] [Full Text] [Related]
18. Transgenic rescue of Krabbe disease in the twitcher mouse.
De Gasperi R; Friedrich VL; Perez GM; Senturk E; Wen PH; Kelley K; Elder GA; Gama Sosa MA
Gene Ther; 2004 Aug; 11(15):1188-94. PubMed ID: 15164096
[TBL] [Abstract][Full Text] [Related]
19. Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy.
Luddi A; Strazza M; Carbone M; Moretti E; Costantino-Ceccarini E
Exp Cell Res; 2005 Mar; 304(1):59-68. PubMed ID: 15707574
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
